MENU

CMRX Chimerix Forecast, Technical & Fundamental Analysis

a developer of novel oral antiviral therapeutics

Industry Biotechnology
CMRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
CMRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

CMRX is expected to report earnings to fall 21.54% to -20 cents per share on March 04

Chimerix CMRX Stock Earnings Reports
Q4'24
Est.
$-0.20
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.23
Q1'24
Missed
by $0.04
Q4'23
Beat
by $0.04
The last earnings report on November 07 showed earnings per share of -25 cents, missing the estimate of -23 cents. With 504.77K shares outstanding, the current market capitalization sits at 80.83M.
A.I. Advisor
published General Information

General Information

a developer of novel oral antiviral therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2505 Meridian Parkway
Phone
+1 919 806-1074
Employees
72
Web
https://www.chimerix.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME27.370.91
+3.44%
GameStop Corp
AAPL228.223.10
+1.38%
Apple
SPY593.35-3.84
-0.64%
SPDR® S&P 500® ETF Trust
BTC.X87250.430000-3333.734400
-3.68%
Bitcoin cryptocurrency
TSLA311.18-19.06
-5.77%
Tesla

CMRX and Stocks

Correlation & Price change

A.I.dvisor tells us that CMRX and DNA have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CMRX and DNA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
-5.40%
DNA - CMRX
30%
Poorly correlated
-15.00%
MDGL - CMRX
28%
Poorly correlated
-3.96%
STRO - CMRX
28%
Poorly correlated
-12.88%
KRYS - CMRX
28%
Poorly correlated
-3.71%
CRBU - CMRX
27%
Poorly correlated
-5.00%
More

Groups containing CMRX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CMRX
1D Price
Change %
CMRX100%
-5.40%
drugs
theme (254 stocks)
21%
Poorly correlated
-4.03%
therapeutics
theme (53 stocks)
17%
Poorly correlated
-5.73%
oral products
theme (5 stocks)
10%
Poorly correlated
-2.87%
biotechnology
theme (238 stocks)
5%
Poorly correlated
-4.32%